Flurry of Acquisitions and Licensing Deals Come Amid JP Morgan Healthcare Conference 2025

Posted on by admin

Organizations including Gilead, Eli Lilly, and AbbVie announced a number of deals addressing inflammatory diseases, multiple myeloma, and other disease areas.

Leave a Reply

Your email address will not be published. Required fields are marked *